Answers are grounded in this paper and cite their sources.
Novel pyrrole-thiazole compounds show strong antioxidant and antidiabetic effects, suggesting potential for drug development.
Objective: In the current study, novel heterocyclic molecules of pyrrole-conjugated thiazole were synthesized for the development of antidiabetic drugs. Methods: (E)-2-(2-((1-substituted-1H-pyrrol-2-yl)methylene)hydrazineyl)thiazole analogues (A1–A12) were synthesized by reacting thiosemicarbazide and substituted formyl pyrrole in ethanol to yield the intermediate 1-substituted pyrrol-2-carbaldehyde thiosemicarbazone, followed by the addition of α-bromoacetophenone in anhydrous ethanol and refluxing for 8 h. The synthesized derivatives were evaluated for antioxidant and antidiabetic activity. Results and Discussion: Compound A11 was found to be the most efficient antioxidant among all synthesized derivatives, with an IC50 value of 15.28 μg/mL. In the α-amylase inhibitory activity assay, derivatives A9 (IC50 = 2.10 ± 0.04 μg/mL), A7 (IC50 = 8.20 ± 0.04 μg/mL), and A11 (IC50 = 12.10 ± 0.04 μg/mL) demonstrated significantly higher potency, with activities surpassing that of acarbose (IC50 = 20.30 ± 0.20 μg/mL). Significant blood glucose lowering effects were displayed by compounds A9 and A11 (162 ± 0.21 and 176 ± 0.15 mg/dL, respectively). Conclusions: The appropriate molecular docking studies, ADME properties, and suitable binding interactions make the pyrrole-substituted thiazole analogues a promising structural motif for further clinical evaluation and the development of a new antidiabetic drug molecule.
No takes yet. Share an insight, caveat, or question.
Sati et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: